Trump confirms Makary out at FDA
President Donald Trump confirmed on Tuesday that Marty Makary would be leaving his post atop the U.S. Food and Drug Administration.
While speaking to reporters on the White House lawn Tuesday, Trump said Makary would be leaving. He said FDA deputy commissioner Kyle Diamantes will take over as the adminsitration seeks a new leader of the federal agency.
“He was having some difficulty,” Trump said. “Marty is a terrific guy, but he’s going to go and lead a good life.”
Trump did not specify what kind of difficulty Makary experienced. Several reports circulated that there was an internal dispute over approval for flavored vapes at the FDA. The Wall Street Journal reported that Trump pressured Makary to approve fruit-flavored vapes, but he was hesitant to do so.
Trump said many people are seeking the job atop the agency.
Makary was expected to testify on Capitol Hill Wednesday to present the FDA’s budget for the upcoming fiscal year. Diamantes is expected to take his place.
Makary was confirmed to lead the FDA in March 2025. Since then, he’s sought to make several changes to the agency’s policies and change organizational structure. Makary sought to limit antidepressants for pregnant women and ban kratom byproducts.
“He’s a friend of mine, he’s a wonderful man and he’s going to be off,” Trump said of Makary.
Latest News Stories
Chicago tax proposals draw concern over legality, ‘economic death spiral’
Illinois quick hits: Former governor proposes millionaire’s surcharge; digital state ID launched
U.S. Senate passes bill to release Epstein files, heads to Trump’s desk
Louisiana Rep. Clay Higgins defends Epstein ‘no’ vote
Abbott designates Muslim Brotherhood, CAIR as foreign terrorist organizations
Judge blocks feds from freezing California education funding
Texas appealing El Paso court ruling against new congressional maps
Elections board drops campaign finance fines against IL Senate President
Senate gears up for Epstein vote
Illinois corrections officials say they are on schedule for prison mail scan rule
Asset managers retreat from ESG push, report finds
U.S. House passes bill to release Epstein files, moves to Senate